[Therapy and prognosis of chronic cor pulmonale].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001067:Appetite Depressants / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy; D002908:Chronic Disease; D004071:Digitalis Glycosides / Q000627:therapeutic use / Q000633:toxicity; D004232:Diuretics / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000150:complications / Q000628:therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010102:Oxygen Inhalation Therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D011379:Prognosis; D011655:Pulmonary Embolism / Q000150:complications* / Q000628:therapy; D011656:Pulmonary Emphysema / Q000150:complications*; D011658:Pulmonary Fibrosis / Q000150:complications*; D011660:Pulmonary Heart Disease / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D013566:Sympathomimetics / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use; D014682:Vena Cava, Inferior / Q000601:surgery
D000305:Adrenal Cortex Hormones; D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001067:Appetite Depressants; D004071:Digitalis Glycosides; D004232:Diuretics; D005343:Fibrinolytic Agents; D005730:Ganglionic Blockers; D007166:Immunosuppressive Agents; D010276:Parasympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents
Therapie und Prognose des chronischen Cor pulmonale.